key: cord-0700187-8teen8vo
authors: Salehi, Mona; Amanat, Man; Mohammadi, Mohammadreza; Salmanian, Maryam; Rezaei, Nima; Saghazadeh, Amene; Garakani, Amir
title: The prevalence of post-traumatic stress disorder related symptoms in Coronavirus outbreaks: A systematic-review and meta-analysis
date: 2021-03-01
journal: J Affect Disord
DOI: 10.1016/j.jad.2020.12.188
sha: 6eac7f889e1cafc2c2985759fdf982c0202e0e1d
doc_id: 700187
cord_uid: 8teen8vo

BACKGROUND: : Infectious disease outbreaks affect physical and mental health of humans worldwide. Studies showed that the prevalence of post-traumatic stress disorder (PTSD) symptoms increased in these conditions. This systematic-review and meta-analysis aimed to assess the prevalence of PTSD related symptoms in coronavirus outbreaks. METHODS: : Systematic search of literature was conducted in Scopus, Embase, PubMed, and Web of Science. Google Scholar and Grey literature including conference proceedings were also checked. Published articles from November 1, 2012 until May 18, 2020 were searched. Subgroup analysis, meta-regression and sensitivity analysis were also conducted to assess heterogeneity. RESULTS: : We found 38 articles with 19,428 individuals met the eligibility criteria. Of these papers, 35 studies were included in meta-analysis. The prevalence of PTSD symptoms was estimated to be about 18% (95%CI: 15% to 20%). These symptoms were more frequent in cohort studies (29%) compared to cross-sectional (15%) and case-control (11%) studies. Prevalence rates of PTSD symptoms in MERS (36%) outbreaks were higher than SARS (18%) and COVID-19 (9%) outbreaks. Meta-regression showed that the geographical location of study was the source of heterogeneity (R(2): 19.8%, P-value: 0.003). Meta-analysis reported that about three in every ten survivors of coronavirus infection, about two in every ten healthcare workers, and about one in every ten individuals of general population experienced PTSD symptoms in outbreaks. LIMITATIONS: : PTSD cannot be objectively assessed and this can lead to information bias of included studies. CONCLUSION: : PTSD symptoms are shown to be common in coronavirus outbreaks. Mental care should be, therefore, considered in the present COVID-19 pandemic.

The Coronaviridae family consists of different viruses that have affected many individuals in the past century. The epidemic outbreak of severe acute respiratory syndrome coronavirus (SARS-CoV) occurred in 26 countries during 2002 to 2003 and led to over 770 deaths with mortality rate ranging from 7% to 17% in most affected areas (WHO, 2003) and up to 50% among elderly population (McIntosh & Perlman, 2015) . The Middle East respiratory syndrome (MERS) was first reported on the Arabian Peninsula in September 2012. The most prevalent country was, however, Republic of Korea in 2015 (CDC, 2014) . The Worldwide mortality rate due to MERS was reported to be 34% (over 850 deaths) (CDC, 2014) . The novel coronavirus known as SARS-CoV-2 that cause Coronavirus disease 2019 was thought to originate in Wuhan, China in December 2019 and declared as a pandemic outbreak by World Health Organization (WHO) on March, 11 th , 2020;  with an estimated 4% to 11% mortality rate (N. Chen et al., 2020; D. Wang et al., 2020) .

Infectious disease outbreaks have not only affected the physical health but also mental health of those infected and even those not infected. Post-traumatic stress disorder (PTSD) and post-traumatic stress disorder related symptoms are prevalent and disabling conditions occur as a consequence of traumatic events. Based on diagnostic and statistical manual of mental disorders fifth edition (DSM-V), PTSD can be diagnosed according to eight criteria (A-H) and consists of symptoms including re-experiencing the traumatic event, intrusive behaviors, avoidance of the stimuli related to the traumatic event, and worsening of cognition and mood after the traumatic event. These symptoms should not be attributable to other disorders (APA, 2013) .

Different studies showed that PTSD and PTSD related symptoms could be common among individuals with medical illnesses. The highest prevalence of PTSD was reported in people admitted to intensive care units and treated for a potentially life threatening disease; mostly due to HIV infection (Tedstone & Tarrier, 2003) . Infectious disease outbreaks can be considered as traumatic events and increase the risk of future PTSD symptoms among different populations; especially affected patients/ survivors (A1 criteria: "directly experiencing the traumatic event (s)") and healthcare workers (A4 criteria: "experiencing repeated or extreme exposure to aversive details of the traumatic event(s)") (APA, 2013) . Some observational studies reported the prevalence of PTSD symptoms among individuals during and after outbreaks of SARS, MERS, This was in the range of 3% among general population to over 40% among the survivors of coronavirus (Liang et al., 2020; Tang et al., 2020) .

The aim of this study is to determine the global prevalence of traumaand stress-related symptoms consistent with PTSD during and after the three most recent coronavirus outbreaks (specifically SARS-CoV, MERS, and SARS-CoV-2), in a variety of population groups including general population, patients/ survivors, and healthcare workers using the systematic review and meta-analysis protocol. The study goal is to ascertain the risk of development of PTSD related symptoms in high risk populations given the importance of mental care during the ongoing COVID-19 pandemic.

We used preferred reporting items for systematic reviews and metaanalyses (PRISMA) to improve the present study (Supplement 1) (Moher, Liberati, Tetzlaff, & Altman, 2009 ). The authors (MaS and MoS) developed the study protocol and published previously (Salmanian, Salehi, & Hooshyari, 2020) .

A systematic search of the literature was conducted in Scopus, Embase, PubMed, and Web of Science to identify studies assessing the prevalence of PTSD during and after coronavirus outbreaks. Published articles from November 1, 2012 until May 18, 2020 were searched. The search strategy was developed using the following MeSh terms: "(Posttraumatic stress OR Post traumatic stress OR PTSD OR PTSS) AND (Coronavirus OR COVID-19 OR COVID19 OR SARS-CoV-2 OR 2019-nCoV OR Wuhan coronavirus OR SARS2 OR severe acute respiratory syndrome coronavirus 2 OR MERS OR SARS OR Middle east respiratory syndrome OR severe acute respiratory syndrome OR SARS-COV OR MERS-COV)". To control publication bias, we searched Google Scholar to find additional articles. Grey literature including conference proceedings was also searched. The reference lists of relevant articles were checked. The last search was performed in May, 2020.

Inclusion criteria were all observational studies reporting data on prevalence of PTSD and PTSD related symptoms during and/or after coronavirus (SARS, MERS, outbreaks or pandemics. Studies on general population, healthcare workers, affected patients with coronavirus, and/or survivors were included. PTSD diagnosis could be according to made either thought a structured clinical interview for DSM-IV or using various instruments; such as post-traumatic stress disorder checklist-civilian version (PCL-C), PCL-reduced version, impact of events scale (IES), IES-revised (IES-R), PTSD checklist for DSM-V (PCL-5), symptom check list 95 (KSCL 95), or Davidson trauma scale. The search was not restricted to any location or language. The exclusion criteria were 1) studies conducted on populations with specific ethnicity, socioeconomic status, and/or educational background; 2) duplicate records; and 3) case-reports and publications other than original articles (e.g. reviews). Three authors (MoS, MaS, MA) independently searched through databases and decided to include or exclude publications based on above-mentioned criteria. Any disagreement was resolved by discussion or it was consulted with other authors (MM and NR).

Two authors (MoS and MaS) independently assessed the methodological quality of included studies using modified strengthening the reporting of observational studies in epidemiology (STROBE) checklist (Vandenbroucke et al., 2014) . We extracted study characteristics; including the first author name, publication year, continent and country where the study took place, study design (cross-sectional, case-control, longitudinal studies), setting (general population, healthcare worker, patient, survivor), type of pandemics or outbreaks (SARS, MERS, , time of measurement, response rate, total sample size, gender, age, instruments measured PTSD, and outcomes measured. The overall inter observer agreement was about 90 percent. In case of any disagreement, third author (MA) reassessed the manuscript.

Data were reported as numbers and percentages with 95% confidence interval (95%CI). All analyses were conducted with STATA (Release 12. statistical software. College Station, Texas: STATA Corp LP). The graphical methods and random-effects models were used to aggregate prevalence estimates. Heterogeneity across the studies was assessed using the I 2 statistic. We used subgroup analysis to assess the possible source of heterogeneity. Subgroup analysis was performed based on the quality of study, the region of study, the study design, type of outbreaks, measurement tools, and time of measurement. Metaregression and Sensitivity analysis were also conducted. The publication bias was assessed using graphical methods and statistical tests; including Egger's and Begg's tests, and Begg's funnel plot. P-values< 0.05 were considered statistically significant.

We identified 1303 records through database searching. Of these papers, 1112 were excluded based on the titles and abstracts; and 114 full-text articles were retrieved after removing duplicate records and finding additional papers through Google Scholar ( Figure 1 ). Overall, 38 articles met the eligibility criteria that are reported in Table 1 .

The eligible studies consisted of 19,428 individuals from 8 countries: Canada (n= 4) (Assar, Moallef, Gardner, & Patcai, 2010; Hawryluck et al., 2004; Lancee, Maunder, & Goldbloom, 2008; Reynolds et al., 2008) , China (n= 11), (Guo et al., 2020; Hao et al., 2020; Hong et al., 2009; Huang & Zhao, 2020; Liang et al., 2020; Liu et al., 2020; Sun et al., 2020; Tang et al., 2020; P. Wu et al., 2009; Yin et al., 2020) , Hong Kong (n= 5) (Lau et al., 2006; Mak et al., 2010; K. K. Wu, Chan, & Ma, 2005a , 2005b , Singapore (n= 6) (Sim, Huak Chan, Chong, Chua, & Wen Soon, 2010; Sin & Huak, 2004; Tan et al., 2020; Chan and Huak, 2004; Tham et al., 2005; Kwek et al., 2006) , Singapore and India (n= 1) , South Korea (n= 7) ( S. H. Lee et al., 2019; S. M. Lee, Kang, Cho, Kim, & Park, 2018; Park et al., 2020; Shin et al., 2019; Um, Kim, Lee, & Lee, 2017; Jung et al., 2020) , Spain (n= 1) (Gonzalez-Sanguino et al., 2020) , and Taiwan (n= 3) (Su et al., 2007; Chen et al., 2005; Chong et al., 2004) . Most included studies assessed the prevalence of PTSD symptoms during or after the SARS outbreak (n= 19) (Assar et al., 2010; Chan and Huak, 2004; C. S. Chen et al., 2005; Chong et al., 2004; Hawryluck et al., 2004; Hong et al., 2009; Kwek et al., 2006; Lancee et al., 2008; Lau, Yang, Tsui, Pang, & Wing, 2006; T. M. Lee, Chi, Chung, & Chou, 2006; Mak et al., 2010; Sim et al., 2010; Sin & Huak, 2004; Su et al., 2007; Tham et al., 2005 ; K. K. Wu et al., 2005a Wu et al., , 2005b P. Wu et al., 2009; Hong et al., 2009) ; followed by COVID-19 (n= 12) Gonzalez-Sanguino et al., 2020; Guo et al., 2020; Hao et al., 2020; Huang & Zhao, 2020 Lee et al., 2006; Park et al., 2020; Reynolds et al., 2008; Sim et al., 2010; Tan et al., 2020; Um et al., 2017; K. K. Wu et al., 2005a K. K. Wu et al., , 2005b P. Wu et al., 2009 ) and IES (n= 9) (Chan and Huak, 2004) ; C. S. Chen et al., 2005; Chong et al., 2004; Hong et al., 2009; Kwek et al., 2006; Lancee et al., 2008; Lau et al., 2006; Sin & Huak, 2004; Tham et al., 2005) were the most frequent measurement tools to diagnose PTSD related symptoms (Table 1) . There were few studies with the same population reported the prevalence rates of PTSD symptoms in different time periods (Assar et al., 2010; Hong et al., 2009 ). In such cases, the highest prevalence rate was included in the meta-analysis. 

The total prevalence rate of 18% (95%CI: 15-20%; I 2 : 97.52%) for PTSD related symptoms was estimated in coronavirus outbreaks (Figure 2 ). Subgroup analysis was performed and the variation in prevalence rates of PTSD symptoms by study characteristics was assessed (Supplement 2). PTSD symptoms were more frequent in cohort based studies (29%) compared to cross-sectional (15%) and case-control (11%) studies. Prevalence rates of PTSD in MERS (36%) outbreaks were also significantly higher than SARS (18%) and COVID-19 (9%) outbreaks.

To explore the source of heterogeneity, meta-regression was conducted. It was identified that the geographical location of study was the source of heterogeneity (R 2 : 19.8%, P-value: 0.003) ( Table 2) . Analyses of publication bias for studies estimated the total prevalence of PTSD was performed and bias was found by both Begg`s test (z= 1.99; Pr= 0.047) and Egger`s test (p= 0.002) ( Figure 3A ).

By specifying I 2 = 10% and tau 2 = 0.25, sensitivity meta-analyses were performed to check the impact of heterogeneity on effect size and the effect size remained significant (tau 2 = 0.25: ES, 0.19 with the 95% CI of [.0258572, .3533172 ], SE, 0.084, p = 0.023, I 2 = 99.9%; I 2 = 10: ES, 0.086 with the 95% CI of [.0811136, .0905173], SE, 0.002, p = 0.000, tau 2 = 0.000).

We found 15 studies estimated the prevalence of PTSD related symptoms among healthcare workers; including 5628 participants from Canada (n= 1) (Lancee et al., 2008) , China (n= 3) (Huang & Zhao, 2020; P. Wu et al., 2009; Yin et al., 2020) , Singapore (n= 4) (Chan and Huak, 2004; Sin & Huak, 2004; W. Tan et al., 2020; Tham et al., 2005) , Singapore and India (n= 1) , South Korea (n= 4) Kim et al., 2018; S. M. Lee et al., 2018; Um et al., 2017) , and Taiwan (n= 2) (C. S. Chen et al., 2005; Su et al., 2007) . One study only reported the mean and standard deviation of the IES score and was excluded from the meta-analysis (Chong et al., 2004) .

The prevalence rate of PTSD related symptoms was estimated to be 18% among healthcare workers (95%CI: 13-24%; I 2 : 97.21%) ( Figure 4A ). By conducting subgroup analysis, no significant differences were observed among variables of each subgroup (Suoolement 2).

We conducted analyses of publication bias for studies estimated the prevalence of PTSD among healthcare workers ( Figure 3B ). No evidence of publication bias was found by Begg`s test (z= 1.73; Pr= 0.083). Egger`s test, however, showed the significant publication bias (p= 0.011).

There were 10 studies assessed the prevalence of PTSD related symtoms among survivors including 794 individuals from Canada (n= 1) (Assar et al., 2010) , China (n= 2) (Guo et al., 2020; Hong et al., 2009 ), Hong Kong (n= 3) (Mak et al., 2010; K. K. Wu et al., 2005a K. K. Wu et al., , 2005b , Singapore (n= 1) (Kwek et al., 2006) , and South Korea (n= 3) (S. H. Lee et al., 2019; Park et al., 2020; Shin et al., 2019) . Two of these studies reported the overlapping samples and the study with larger sample size was included in the meta-analysis (K. K. Wu et al., 2005a Wu et al., , 2005b We estimated the prevalence rate of 29% for PTSD related symptoms among survivors of coronavirus (CI: 18-39%; I 2 : 96.14%) ( Figure 4B ). Subgroup analysis showed that prevalence rate of PTSD or PTSD related symptoms in longitudinal studies and during outbreaks was statistically higher than cross-sectional studies and after outbreaks; respectively (Supplement 2). Analyses of publication bias showed no evidence of publication bias by both Begg`s test (z= 0.00; Pr= 1.00) and Egger`s test (p= 0.59) ( Figure 3C ).

We found 12 studies estimated the prevalence of PTSD or PTSD related symptoms among general population including 13006 (Hawryluck et al., 2004; Reynolds et al., 2008) , China (n= 6) (Guo et al., 2020; Hao et al., 2020; Liang et al., 2020; Liu et al., 2020; Sun et al., 2020; Tang et al., 2020) , Hong Kong (n= 2) (Lau et al., 2006; T. M. Lee et al., 2006) , Singapore (n= 1) (B. Y. Tan et al., 2020) , and Spain (n= 1) (Gonzalez-Sanguino et al., 2020) . One study only reported the mean and standard deviation of the scores and thus was excluded from the meta-analysis (C. ; One study assessed the prevalence rates in two different populations (general population and survivors) and both were included in the meta-analysis (Guo et al., 2020) . The prevalence rates of 12% were estimated for PTSD related symptoms among general population (95%CI: 8-16%; I 2 : 98.27%) ( Figure 4C ). By conducting subgroup analysis, no significant differences were observed among variables of each subgroup (Supplement 2).

Analyses of publication bias were performed for studies estimated the prevalence of PTSD related symptoms among general population ( Figure 3D ). No evidence of publication bias was found by Begg`s test (z= 1.51; Pr= 0.13) but Egger`s test indicated the significant publication bias (p= 0.006).

To our knowledge, this is the first systematic review and metaanalysis assessed the prevalence of PTSD or PTSD related symptoms among different populations across the three most recent coronavirus outbreaks. Our meta-analysis showed that about three in every ten survivors of coronavirus infection, about two in every ten healthcare workers, and about one in every ten individuals of general population were reported to have a diagnosis of PTSD or PTSD related symptoms during and/or after outbreaks. Most studies included in this systematicreview were about epidemic SARS outbreaks that affected approximately 8100 individuals worldwide. We are now in the middle of pandemic COVID-19 outbreak with over 43 million diagnosed cases and more than 1 million deaths, as of October 2020. This can be a great warning to all of us that people will be in great risk of developing psychiatric disorders including PTSD. Mental care should not be, therefore, underestimated at the present time; especially for the survivors of the disease.

PTSD is an anxiety disorder that can significantly affect the quality of lives of people. It was estimated that the global prevalence of this condition was 1.1% in 2014 (Karam et al., 2014) . Our study showed that infectious disease outbreaks could significantly increase the prevalence rate of PTSD. For years, the burden of anxiety disorders was underestimated due to limited numbers of surveys in this field. It is now found that anxiety disorders are the sixth leading cause of years with life disabilities in high and middle to low income countries (Baxter et al., 2014) . Studies showed that PTSD was associated with higher risk of future physical and psychiatric co-morbidities. Depression, substance use, suicide, and chronic illness are more common among these individuals (Karatzias et al., 2019) . A four-year follow-up study in China reported that patients that survived from SARS outbreak and were diagnosed with PTSD had severe and persistent psychiatric symptoms that affected both mental and physical health (Hong et al., 2009) .

Some studies assessed the risk factors of developing PTSD in coronavirus outbreaks. Among healthcare workers, level of exposure to the infectious disease and duration of contacts with infected people were important risk factor (Carmassi et al., 2020) . Two case-control studies during SARS outbreaks in China and Taiwan reported that staff of emergency departments were at up to 3 times increased risk of PTSD development compared to healthcare workers of non-emergency departments (Lin et al., 2007; P. Wu et al., 2009) . Another study conducted in Toronto, Canada, showed that SARS outbreaks had higher impact on nurses and they had higher IES score compared to other hospital workers. This could be due to longer contacts with infected people (Maunder et al., 2003) . Quarantine and previous psychiatric disorders were other reported risk factors of PTSD among healthcare workers (Carmassi et al., 2020) . Among general population, one study during COVID-19 outbreak on 2485 university students, showed that being an only child, short sleep duration, living in the worst-hit areas, and students who were in the final year of university were significantly at higher risk of developing PTSD (Tang et al., 2020) .

There were some limitations to our study. High heterogeneity was seen between studies and about half of the studies had low quality. These factors can make interpretation and generalization of results challenging. Objective assessment of PTSD symptoms is limited and the diagnosis is reliant on reports of individuals and self-report rating scales that can lead to information bias in our included studies. Numbers of published papers about the association between COVID-19 outbreaks and risk of developing PTSD were limited until the date we searched. Future systematic-reviews should assess this correlation. Risk factors and predictors of PTSD development were not evaluated in our study that should be resolved in future studies. Observational studies with long-term follow-up periods should also be conducted to show the prognosis and risk of developing future mental and physical comorbidities.

In conclusion, PTSD or PTSD related symptoms were shown to be common in coronavirus outbreaks in the last two decades. Mental health care should be considered to prevent this condition during and after pandemic COVID-19 outbreaks.

Manuscript Title: The Prevalence of Post-Traumatic Stress Disorder Related Symptoms in Coronavirus Outbreaks: A Systematic-Review and Meta-Analysis All persons who meet authorship criteria are listed as authors, and all authors certify that they have participated sufficiently in the work to take public responsibility for the content, including participation in the concept, design, analysis, writing, or revision of the manuscript. Furthermore, each author certifies that this material or similar material has not been and will not be submitted to or published in any other publication before its appearance in the Journal of Affective Disorders List of authors: Mona Salehi, Man Amanat, Mohammadreza Mohammadi, Maryam Salmanian, Nima Rezaei, Amene Saghazadeh, Amir Garakani,

Mona Salehi: Acquisition of data; Analysis and/or interpretation of data; Drafting the manuscript Man Amanat: Acquisition of data; Analysis and/or interpretation of data; Drafting the manuscript Mohammadreza Mohammadi: Conception and design of the study; Revising the manuscript critically for important intellectual content Maryam Salmanian: Acquisition of data; Analysis and/or interpretation of data; Drafting the manuscript Nima Rezaei: Conception and design of the study; Revising the manuscript critically for important intellectual content Amene Saghazadeh: Analysis and/or interpretation of data Amir Garakani: Revising the manuscript critically for important intellectual content All the authors approved the final version of the manuscript.

All authors declare no conflict of interest.

Diagnostic and statistical manual of mental disorders (DSM-5®)

PREDICTORS OF PTSD IN SARS SURVIVORS

The global burden of anxiety disorders in 2010

PTSD symptoms in healthcare workers facing the three coronavirus outbreaks: What can we expect after the COVID-19 pandemic

Psychological impact of the 2003 severe acute respiratory syndrome outbreak on health care workers in a medium size regional general hospital in Singapore

Psychological distress of nurses in Taiwan who worked during the outbreak of SARS

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak

Psychological impact of severe acute respiratory syndrome on health workers in a tertiary hospital

Mental Health Consequences during the Initial Stage of the 2020 Coronavirus Pandemic (COVID-19) in Spain

Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: a mixed-method study

Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry

SARS control and psychological effects of quarantine

Posttraumatic stress disorder in convalescent severe acute respiratory syndrome patients: a 4-year followup study

Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey

Assessing the Presence of Post-Traumatic Stress and Turnover Intention Among Nurses Post-Middle East Respiratory Syndrome Outbreak: The Importance of Supervisor Support. Workplace health & safety

Cumulative traumas and risk thresholds: 12-month PTSD in the World Mental Health (WMH) surveys

Risk factors and comorbidity of ICD-11 PTSD and complex PTSD: Findings from a trauma-exposed population based sample of adults in the United Kingdom

Effects of Middle East Respiratory Syndrome Coronavirus on post-traumatic stress disorder and burnout among registered nurses in South Korea

Quality of life and psychological status in survivors of severe acute respiratory syndrome at 3 months postdischarge

Prevalence of psychiatric disorders among Toronto hospital workers one to two years after the SARS outbreak

Positive mental healthrelated impacts of the SARS epidemic on the general public in Hong Kong and their associations with other negative impacts

Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle east respiratory syndrome survivors

Psychological impact of the 2015 MERS outbreak on hospital workers and quarantined hemodialysis patients

Ageing and psychological response during the post-SARS period

The Effect of COVID-19 on Youth Mental Health

The psychological effect of severe acute respiratory syndrome on emergency department staff

Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: Gender differences matter

Risk factors for chronic post-traumatic stress disorder (PTSD) in SARS survivors

The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital

Coronaviruses, including severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS)

s Principles and Practice of Infectious Diseases

Posttraumatic stress disorder and depression of survivors 12 months after the outbreak of Middle East respiratory syndrome in South Korea

Understanding, compliance and psychological impact of the SARS quarantine experience

Global Prevalence of Posttraumatic Stress Disorder (PTSD) during and after Coronavirus Pandemic: A Study Protocol for a Systematic Review and Meta-Analysis

Psychiatric Morbidity of Survivors One Year after the Outbreak of Middle East Respiratory Syndrome in Korea

Psychosocial and coping responses within the community health care setting towards a national outbreak of an infectious disease

Psychological impact of the SARS outbreak on a Singaporean rehabilitation department

Prevalence of psychiatric morbidity and psychological adaptation of the nurses in a structured SARS caring unit during outbreak: A prospective and periodic assessment study in Taiwan

Prevalence and risk factors of acute posttraumatic stress symptoms during the COVID-19 outbreak in Wuhan

Psychological impact of the COVID-19 pandemic on health care workers in Singapore

Prevalence and correlates of PTSD and depressive symptoms one month after the outbreak of the COVID-19 epidemic in a sample of home-quarantined Chinese university students

Posttraumatic stress disorder following medical illness and treatment

Psychological Morbidity among Emergency Department Doctors and Nurses after the SARS Outbreak

Psychological effects on medical doctors from the Middle East Respiratory Syndrome (MERS) outbreak: A comparison of whether they worked at the MERS occurred hospital or not, and whether they participated in MERS diagnosis and treatment

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration

A longitudinal study on the mental health of general population during the COVID-19 epidemic in China

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan. China

Summary of probable SARS cases with onset of illness from 1

Posttraumatic stress after SARS

Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS)

The psychological impact of the SARS epidemic on hospital employees in China: exposure, risk perception, and altruistic acceptance of risk

Posttraumatic Stress Symptoms of Health Care Workers during the Corona Virus Disease

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.jad.2020.12.188.